Trial Profile
Clinical Trial on the Effectiveness of the Flavonoids Genistein and Quercetin in Men With Rising Prostate-specific Antigen
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Genistein (Primary) ; Quercetin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms QUERGEN
- 24 Nov 2015 The recruitment status of this study is unknown because the information has not been verified recently (Verified on May 2012). Kept previous status as recruiting as per ClinicalTrials.gov record.
- 08 May 2013 Interim results presented at the 108th Annual Meeting of the American Urological Association.
- 18 Mar 2013 Interim results (n=18) presented at the 28th Congress of the European Association of Urology.